Title: Precancerous Risk Assessment of the Gastric Atrophy by Tri-modal Endoscopy
Authors: Fathi Ghamry Abdelrazek, Magdy Abd Elkareem Eldahshan, Shadia Hussein Mabrouk, Atef Aboelfotoh Ibrahim, Mohamed Salah Ali Hussein, Mohamed Samy EL Shahawy, Zakaria Mohamed Zakaria, Ahmed Ibrahim Gawish
DOI: https://dx.doi.org/10.18535/jmscr/v5i7.148
Abstract
Background / Aims: Gastritis staging and detection of pre-neoplastic gastric mucosal changes based on the histology of biopsy specimen imposes a considerable burden on endoscopist and pathologist. Therefore, we attempted to evaluate whether gastritis staging system based on the using of conventional high-resolution white light endoscopy(WLE), Auto fluorescence imaging(AFI),and narrow band imaging(NBI) is equivalent to that determined by histopathology.
Methods: This study included 63 egyptian patients who were diagnosed with chronic gastritis. The lesser curvature of the antrum (2 cm from the pyloric ring) and the lesser curvature of the lower body (4 cm from the angle) were examined in consecutive order first by high resolution WLE followed by AFI and finally by NBI. Two endoscopic biopsies were taken from gastric antrum and lower gastric body for histopathological assessment of H. Pylori infestation, gastric atrophy and intestinal metaplasia (IM).The lower gastric body atrophy was graded according to OLIGA scoring system (Operative Link for Gastritis Assessment) . Additionally, the presence or absence of IM was examined in both lower gastric body and antrum.
Results: By means of WLE and AFI, the patients were found to have no, mild, moderate and severe gastric atrophy in 8(16%), 18(36%), 8(16%), and 16(32%) respectively. Furthermore, Gastric atrophy was detected in all patients by NBI with mild, moderate and severe atrophy in 15(30%), 24(48%) and 11(22%) respectively. as a result of histopathological assessment, 12(24%), 34(68%), and 4(8%) had scores 1, 2 and 3 by OLIGA scoring systems respectively. in view of scoring system of gastric atrophy and intestinal metaplasia, New staging system for gastritis risk assessment was correctly identified Furthermore, Gastric cancer risk stages were recognized and the degree of correspondence on the basis of NBI and combined WLE , AFI on one hand and histopathology on the other hand were 80% and 68%.
Conclusion: This study demonstrates that staging of premalignant gastric lesions with conventional NBI has better correspondence with histopathology compared with WLE and AFI and can be used for screening early malignancies of the stomach .
Keywords: Narrow-band imaging, Auto-fluorescence imaging, Intestinal metaplasia, white -light endoscopy, Gastric atrophy.
References
1. Ferlay J, Soerjomataram I, Ervik M, et al .GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet].Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on day/month/year.
2. Soetikno R, Kaltenbach T, Yeh R, et al. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol.2005;23:4490-8.
3. Correa P. Chronic gastritis as a cancer precursor. Scand J Gastroenterol Suppl. 1984;104:131–136.
4. de Vries AC, van Grieken NC, Looman CW, Casparie , et al . Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945–952.
5. Areia M, Carvalho R, Cadime AT, Rocha Gonçalves F, Dinis-Ribeiro M.et al., (2013). Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies. Helicobacter;18:325-337.
6. Rugge M, Kim JG, Mahachai V, et al. OLGA gastritis staging in young adults and country-specific gastric cancer risk. Int J Surg Pathol. 2008; 16: 150-154.
7. Capelle LG, de Vries AC, Haringsma , et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointestinal Endoscopy. 2010 ; 71:1150-1158.
8. Kawamura M, Abe S, Oikawa K , et al . Topographic differences in gastric micromucosal patterns observed by magnifying endoscopy with narrow band imaging. J Gastroenterol Hepatol. 2011;26:477–483.
9. Kimura K and Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis.Endoscopy1969; 3:987–979.
10. Alaboudy A, Elbahrawy A, Matsumoto S , Yoshizawa A . Conventional Narrow-Band Imaging Has Good Correlation with Histopathological Severity of Helicobacter pylori Gastritis . Dig Dis Sci. 2011 ; 56:1127–1130.
11. Yao K . Light Blue Crests (LBCs) and White Opaque Substance (WOS).Zoom Gastroscopy. 2014; Japan: Springer; 73–81.
12. So J, Rajnakova A, Chan YH, Tay A, Shah N, Salto-Tellez M, et al. Endoscopic tri-modal imaging improves detection of gastric intestinal metaplasia among a high-risk patient population in Singapore. Dig Dis Sci. 2013;58:3566–3575. doi:
13. Yoon H, Kim N . Diagnosis and management of high risk group for gastric cancer. Gut Liver. 2015 ; 9(1):5-17. doi: 10.5009/gnl14118.
14. Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56:631–636. doi: 10.1136/gut.2006.106666.
15. Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of pre-cancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) Endoscopy. 2012;44:74–94. doi: 10.1055/s-0031-1291491.
16. Cho SJ, Choi IJ, Kook MC, et al. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems. Aliment Pharmacol Ther. 2013;38: 1292–1302. doi: 10.1111/apt.12515.
17. Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinicopathological follow-up study. Aliment Pharmacol Ther. 2010;31:1104–1111.
18. Saka A, Yagi K and Nimura S. OLGA- and OLGIM-based staging of gastritis using narrowband imaging magnifying endoscopyDigestive Endoscopy 2015; 27: 735–742.
Mohamed Samy EL Shahawy
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.